Sloanea zuliaensis
Sloanea zuliaensis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Sloanea zuliaensis is a specialized botanical species that has garnered significant scientific interest due to its unique chemical properties. Researchers have focused their investigations on the plant's leaf, which serves as a primary source of bioactive compounds. Studies have revealed that these leaf extracts exhibit notable cytotoxic activities against various cell lines. Understanding these mechanisms provides crucial insights into the plant's potential role in pharmacological development. Consequently, this species represents a promising subject for ongoing studies in natural product chemistry.
- Synonyms
- Sloanea Macropoda · Sloanea Microcephala
- Common names
- Not available
- Family
- Elaeocarpaceae
- Distribution
- Southern America
- Plant Parts
- Leaf
Classification
Synonyms
Sloanea zuliaensis is a botanical species that has been subject to various taxonomic reclassifications over time. Within scientific literature, it is frequently noted that this plant is associated with several synonymous names. Specifically, the names Sloanea macropoda and Sloanea microcephala are recognized as synonyms for this particular taxon. Understanding these overlapping designations is essential for researchers navigating complex plant databases. Consequently, recognizing these synonyms ensures accurate identification and communication within the field of botany.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Sloanea zuliaensis is a remarkable organism that belongs to the vast kingdom Plantae. Within this kingdom, it is classified under the class Equisetopsida and the order Oxalidales. Its specific taxonomic journey continues through its placement in the family Elaeocarpaceae. Furthermore, this species is a distinguished member of the genus Sloanea. Understanding these biological connections provides essential insight into its place within the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Oxalidales |
| Family | Elaeocarpaceae |
| Genus | Sloanea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Sloanea zuliaensis is a plant species with a broad and diverse geographical range spanning across several tropical regions. Its distribution extends through Central America, specifically reaching into Costa Rica and Panamá. Within the continent of South America, the species is found in Northern South America, particularly within Venezuela. It also maintains a presence in Western South America, making itself at home in both Colombia and Ecuador. This widespread occurrence highlights the plant's ability to thrive in various ecological niches throughout these territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Sloanea zuliaensis is a self-supporting plant that establishes a sturdy presence within its ecosystem. This species takes on a distinctive tree growth form, allowing it to reach significant heights in the canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Sloanea zuliaensis has been identified as a significant source of bioactive cucurbitacin constituents. Researchers successfully isolated several key compounds from the plant, including a new analogue known as 2-deoxycucurbitacin D. Interestingly, certain compounds were found exclusively within the young leaves rather than the mature foliage. These isolated substances demonstrated potent cytotoxic activity against various human cancer cell lines. Specifically, the extracts showed promise in targeting breast, lung, and central nervous system malignancies.
Compounds
Sloanea zuliaensis has been identified as a significant source of specialized cytotoxic constituents. Specifically, researchers have successfully isolated the cucurbitacin D analogue known as 2-deoxycucurbitacin D from this plant species. In addition to this discovery, the plant also contains cucurbitacin D and 25-acetylcucurbitacin F. Notably, the presence of 2-deoxycucurbitacin D appears to be limited to the young leaves rather than the mature foliage. These specific compounds have demonstrated potent activity against various human cancer cell lines, including those from the breast, lung, and central nervous system.
Conditions
Sloanea zuliaensis contains specific cucurbitacin constituents that exhibit potent cytotoxic activity against various human cancer cell lines. These bioactive compounds demonstrate a significant ability to treat breast cancer by targeting the MCF-7 cell line. Furthermore, the plant's extracts show effectiveness against lung cancer through the inhibition of H-460 cells. The medicinal potential of the species also extends to the central nervous system, specifically targeting SF-268 cells. Consequently, these relationships highlight the plant's therapeutic relevance in combating diverse forms of malignancy.
Preparations
Parts used
Sloanea zuliaensis serves as a rich source of unique chemical compounds, particularly within its foliage. Researchers have identified several cytotoxic cucurbitacin constituents isolated specifically from the plant's leaves. Notably, the compound 2-deoxycucurbitacin D was found exclusively in the young leaves rather than the mature ones. These isolated substances, including cucurbitacin D and 25-acetylcucurbitacin F, exhibit significant biological potential. Most importantly, these leaf-derived compounds demonstrate potent cytotoxic activity against various human cancer cell lines.